参考文献/References:
[1] Feng R,Li Y,Wang C,et al.Higher vaspin levels in subjects with obesity and type 2 diabetes mellitus: a meta-analysis[J].Diabetes Res Clin Pract,2014,106(1):88-94.DOI:10.1016/j.diabres.2014.07.026.
[2] Teshigawara S,Wada J,Hida K,et al.Serum vaspin concentrations are closely related to insulin resistance, and rs77060950 at SERPINA12 genetically defines distinct group with higher serum levels in Japanese population[J].J Clin Endocrinol Metab,2012,97(7):E1202-E1207.DOI:10.1210/jc.2011-3297.
[3] Gulcelik NE,Karakaya J,Gedik A,et al.Serum vaspin levels in type 2 diabetic women in relation to microvascular complications[J].Eur J Endocrinol,2009,160(1):65-70.DOI:10.1530/EJE-08-0723.
[4] Li K,Li L,Yang M,et al.Short-term continuous subcutaneous insulin infusion decreases the plasma vaspin levels in patients with type 2 diabetes mellitus concomitant with improvement in insulin sensitivity[J].Eur J Endocrinol,2011,164(6):905-910.DOI:10.1530/EJE-10-1023.
[5] Kovacs P,Miehle K,Sandner B,et al.Insulin administration acutely decreases vaspin serum concentrations in humans[J].Obes Facts,2013,6(1):86-88.DOI:10.1159/000348836.
[6] Tanna N,Patel K,Moore AE,et al.The relationship between circulating adiponectin, leptin and vaspin with bonemineral density(BMD), arterial calcification and stiffness: a cross-sectional study in post-menopausal women[J].J Endocrinol Invest,2017,40(12):1345-1353.DOI:10.1007/s40618-017-0711-1.
[7] Fasshauer M,Blüher M.Adipokines in health and disease[J].Trends Pharmacol Sci,2015,36(7):461-470.DOI:10.1016/j.tips.2015.04.014.
[8] Sathyaseelan AJ,Adole PS,Wyawahare M,et al.Assessment of serum VASPIN levels among type 2 diabetes mellitus patients with or without acute coronary syndrome[J].J Clin Diagn Res,2016,10(12):BC07-BC10.DOI:10.7860/JCDR/2016/22417.8952.
[9] Hao F,Zhang H,Zhu J,et al.Association between vaspin level and coronary artery disease in patients with type 2 diabetes[J].Diabetes Res Clin Pract,2016,113:26-32.DOI:10.1016/j.diabres.2015.12.001.
[10] Yang W,Li Y,Tian T,et al.Serum vaspin concentration in elderly patients with type 2 diabetes mellitus and macrovascular complications[J].BMC Endocr Disord,2017,17(1):67.DOI:10.1186/s12902-017-0216-0.
[11] Yang W,Li Y,Wang JY,et al.Circulating levels of adipose tissue-derived inflammatory factors in elderly diabetes patients with carotid atherosclerosis: a retrospective study[J].Cardiovasc Diabetol,2018,17(1):75.DOI:10.1186/s12933-018-0723-y.
[12] Jung CH,Lee WJ,Hwang JY,et al.Vaspin protects vascular endothelial cells against free fatty acid-induced apoptosis through a phosphatidylinositol 3-kinase/Akt pathway[J].Biochem Biophys Res Commun,2011,413(2):264-269. DOI:10.1016/j.bbrc.2011.08.083.
[13] Nakatsuka A,Wada J,Iseda I,et al.Visceral adipose tissue-derived serine proteinase inhibitor inhibits apoptosis of endothelial cells as a ligand for the cell-surface GRP78/voltage-dependent anion channel complex[J].Circ Res,2013,112(5):771-780.DOI:10.1161/CIRCRESAHA.111.300049.
[14] Phalitakul S,Okada M,Hara Y,et al.Vaspin prevents methylglyoxal-induced apoptosis in human vascular endothelial cells by inhibiting reactive oxygen species generation[J].Acta Physiol(Oxf),2013,209(3):212-219.DOI:10.1111/apha.12139.
[15] Jung CH,Lee WJ,Hwang JY,et al.Vaspin increases nitric oxide bioavailability through the reduction of asymmetric dimethylarginine in vascular endothelial cells[J].PLoS One,2012,7(12):e52346.DOI:10.1371/journal.pone.0052346.
[16] Sun N,Wang H,Wang L.Vaspin alleviates dysfunction of endothelial progenitor cells induced by high glucose via PI3K/Akt/eNOS pathway[J].Int J Clin Exp Pathol,2015,8(1):482-489.
[17] Kameshima S,Yamada K,Morita T,et al.Visceral adipose tissue-derived serine protease inhibitor augments acetylcholine-induced relaxation via the inhibition of acetylcholine esterase activity in rat isolated mesenteric artery[J].Acta Physiol(Oxf),2016,216(2):203-210.DOI:10.1111/apha.12563.
[18] Phalitakul S,Okada M,Hara Y,et al. A novel adipocytokine, vaspin inhibits platelet-derived growth factor-BB-induced migration of vascular smooth muscle cells[J].Biochem Biophys Res Commun,2012,423(4):844-849.DOI:10.1016/j.bbrc.2012.06.052.
[19] Sato K,Shirai R,Yamaguchi M,et al.Anti-Atherogenic effects of vaspin on human aortic smooth muscle cell/macrophage responses and hyperlipidemic mouse plaque phenotype[J].Int J Mol Sci,2018,19(6):pii:E1732.DOI:10.3390/ijms19061732.
[20] Li H,Peng W,Zhuang J,et al.Vaspin attenuates high glucose-induced vascular smooth muscle cells proliferation and chemokinesis by inhibiting the MAPK, PI3K/Akt, and NF-κB signaling pathways[J].Atherosclerosis,2013,228(1):61-68.DOI:10.1016/j.atherosclerosis.2013.02.013.
[21] Radhakrishnan Y,Busby WH Jr,Shen X,et al.Insulin-like growth factor-I-stimulated insulin receptor substrate-1 negatively regulates Src homology 2 domain-containing protein-tyrosine phosphatasesubstrate-1 function in vascular smooth muscle cells[J].J Biol Chem,2010,285(21):15682-15695.DOI:10.1074/jbc.M109.092270.
[22] Kameshima S,Sakamoto Y,Okada M,et al.Vaspin prevents elevation of blood pressure through inhibition of peripheral vascular remodelling in spontaneously hypertensive rats[J].Acta Physiol(Oxf),2016,217(2):120-129.DOI:10.1111/apha.12636.
[23] Gao JH,Zeng MY,Yu XH,et al.Visceral adipose tissue-derived serine protease inhibitor accelerates cholesterol efflux by up-regulating ABCA1 expression via the NF-κB/miR-33a pathway in THP-1macropahge-derived foam cells[J].Biochem Biophys Res Commun,2018,500(2):318-324.DOI:10.1016/j.bbrc.2018.04.066.
[24] Nakatsuka A,Wada J,Iseda I,et al.Vaspin is an adipokine ameliorating ER stress in obesity as a ligand for cell-surface GRP78/MTJ-1 complex[J].Diabetes,2012,61(11):2823-2832.DOI:10.2337/db12-0232.
[25] Lin Y,Zhuang J,Li H,et al.Vaspin attenuates the progression of atherosclerosis by inhibiting ER stress-induced macrophage apoptosis in apoE-/- mice[J].Mol Med Rep,2016,13(2):1509-1516.DOI:10.3892/mmr.2015.4708.
[26] Jung CH,Lee MJ,Kang YM,et al.Vaspin inhibits cytokine-induced nuclear factor-kappa B activation and adhesion molecule expression via AMP-activated protein kinase activation in vascular endothelial cells[J].Cardiovasc Diabetol,2014,13:41.DOI:10.1186/1475-2840-13-41.
[27] Phalitakul S,Okada M,Hara Y,et al.Vaspin prevents TNF-α-induced intracellular adhesion molecule-1 via inhibiting reactive oxygen species-dependent NF-κB and PKCθ activation in cultured rat vascular smooth muscle cells[J].Pharmacol Res,2011,64(5):493-500.DOI:10.1016/j.phrs.2011.06.001.
[28] Weiner J,Zieger K,Pippel J,et al.Molecular mechanisms of vaspin action-from adipose tissue to skin and bone, from blood vessels to the brain[J].Adv Exp Med Biol,2018,[Epub ahead of print].DOI:10.1007/5584_2018_241.
相似文献/References:
[1]赵紫琴,雒瑢,田凤石,等.替米沙坦对OLETF大鼠皮下和内脏脂肪组织PPARγ表达的影响[J].国际内分泌代谢杂志,2014,(06):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
Zhao Ziqin*,Luo Rong,Tian Fengshi,et al.Effects of telmisartan on expression of PPARγ in subcutaneous and visceral adipose tissue in OLETF rats[J].International Journal of Endocrinology and Metabolism,2014,(04):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
[2]姚霜霜,张翼飞,张志国,等.小檗碱改善代谢性疾病的肠道相关机制[J].国际内分泌代谢杂志,2014,(06):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
Yao Shuangshuang,Zhang Yifei,Zhang Zhiguo,et al.The gut-related mechanisms of berberine in the treatment of metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(04):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
[3]曹萌 韦晓 刘超.自噬与胰岛β细胞功能及2型糖尿病[J].国际内分泌代谢杂志,2015,(01):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
Cao Meng,Wei Xiao,Liu Chao..Relationship between autophagy and islet β cells function, type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(04):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
[4]刘艳 田秀标 韩颖.GLP-1受体激动剂呈葡萄糖依赖性刺激胰岛β细胞胰岛素分泌的机制[J].国际内分泌代谢杂志,2015,(01):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
Liu Yan*,Tian Xiubiao,Han Ying..Mechanism of GLP-1 receptor agonists in the stimulation of insulin secretion of islet β cell in a glucose-dependent manner[J].International Journal of Endocrinology and Metabolism,2015,(04):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
[5]齐利琴,刘礼斌.GLP-1在2型糖尿病诱发的阿尔茨海默病治疗中的作用[J].国际内分泌代谢杂志,2016,36(01):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
Qi Liqin,Liu Libin..Effects of GLP-1 in the treatment of Alzheimer's disease induced by type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(04):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
[6]梅稳,向光大,卢俊颜,等.GDF11对ApoE-/-糖尿病小鼠内皮依赖性
血管舒张功能的作用[J].国际内分泌代谢杂志,2016,36(02):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
Mei Wen*,Xiang Guangda,Lu Junyan,et al.Effects of GDF11 on endothelium-dependent vasodiation function of aorta in ApoE-/- diabetic mice[J].International Journal of Endocrinology and Metabolism,2016,36(04):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
[7]殷俏,张云良,郭淑芹,等.视黄醇结合蛋白4、超敏C反应蛋白
与糖尿病视网膜病变的关系[J].国际内分泌代谢杂志,2016,36(03):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
Yin Qiao,Zhang Yunliang,Guo Shuqin,et al.Relationship of retinol binding protein 4 and high sensitive C-reactive protein with diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2016,36(04):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
[8]王涛,张洁,祁范范,等.不同糖耐量人群血清25(OH)D3水平
及与胰岛β细胞功能的关系[J].国际内分泌代谢杂志,2016,36(04):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
Wang Tao*,Zhang Jie,Qi Fanfan,et al.Relationship between serum 25(OH)D3 level and islet β cell function in individuals with different glucose tolerance[J].International Journal of Endocrinology and Metabolism,2016,36(04):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
[9]陈双双,王楚媛,孔令芳.铬与2型糖尿病[J].国际内分泌代谢杂志,2016,36(04):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
Chen Shuangshuang,Wang Chuyuan,Kong Lingfang.Chromium and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2016,36(04):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
[10]涂萍,许婷,段鹏,等.25-羟维生素D3补充对绝经后2型糖尿病
患者胰岛素敏感性及血糖控制的影响[J].国际内分泌代谢杂志,2016,36(05):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]
Tu Ping,Xu Ting,Duan Peng,et al.Influence of 25-hydroxyvitamin D3 supplement on insulin sensitivity and glucose control in postmenopausal patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(04):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]